Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Show other versions (1)

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2014

Antzeko izenburuak

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
nork: Latimer, N, et al.
Argitaratua: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
nork: Guerry, M, et al.
Argitaratua: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
nork: Flossmann, O, et al.
Argitaratua: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
nork: Michael A Paley, et al.
Argitaratua: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Robson, J, et al.
Argitaratua: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
nork: Basu, N, et al.
Argitaratua: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
nork: Pearce, F, et al.
Argitaratua: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
nork: Thomas Hellmark, et al.
Argitaratua: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
nork: Fahidah Alenzi, et al.
Argitaratua: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
nork: Valentina Binda, et al.
Argitaratua: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
nork: Alan D. Salama
Argitaratua: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Cheng-Hua Weng, et al.
Argitaratua: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
nork: Robson, J, et al.
Argitaratua: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
nork: Saket Jha, et al.
Argitaratua: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
nork: Xinyu Weng, et al.
Argitaratua: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
nork: Shiyu Xiao, et al.
Argitaratua: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Christopher Maximilian Arends, et al.
Argitaratua: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
nork: Haiting Wu, et al.
Argitaratua: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Marta Casal Moura, et al.
Argitaratua: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
nork: Daisuke Tsukui, et al.
Argitaratua: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
nork: Hellmich, B, et al.
Argitaratua: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
nork: Laura S. van Dam, et al.
Argitaratua: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
nork: Luqmani, R, et al.
Argitaratua: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
nork: E. N. Vorkel, et al.
Argitaratua: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Weijun Liu, et al.
Argitaratua: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: Si-wei Tang, et al.
Argitaratua: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
nork: Anders Esberg, et al.
Argitaratua: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
nork: Muskan Agarwal MD, et al.
Argitaratua: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: K. Kaynar, et al.
Argitaratua: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
nork: Liye Suo, et al.
Argitaratua: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
nork: Naidan Zhang, MS, et al.
Argitaratua: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
nork: Salomon R, et al.
Argitaratua: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
nork: CM Wortel, et al.
Argitaratua: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
nork: David Massicotte-Azarniouch, et al.
Argitaratua: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
nork: Mukhtyar, C, et al.
Argitaratua: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
nork: Zhi-Ying Li, et al.
Argitaratua: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
nork: Moog P, et al.
Argitaratua: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
nork: Despina Michailidou, et al.
Argitaratua: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
nork: McLaren, J, et al.
Argitaratua: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
nork: Takashi Nawata, et al.
Argitaratua: (2021-04-01)